A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial

This post-market study is monitoring the safety and outcomes of patients who use the Hemovent ECMO device — a machine that temporarily takes over the work of the heart and/or lungs for critically ill patients when these organs are failing. **You may be eligible if...** - You are experiencing severe heart failure, severe respiratory failure, or both - You meet specific clinical criteria showing your heart or lungs are unable to function adequately on their own (e.g., very low oxygen levels or dangerously high CO2) - You need urgent intubation or cardiac surgery **You may NOT be eligible if...** - You or your family refuse ECMO treatment - You have conditions that make ECMO inappropriate (as determined by your care team) Talk to your doctor to see if this trial is right for you.